药物流:一个人工智能驱动的一站式平台,用于创新的药物发现
Chao Shen1,2, Jianfei Song1, Chang-Yu Hsieh1,2
1Hangzhou Carbonsilicon AI Technology Co., Ltd., Hangzhou 310018, Zhejiang, China.
Journal of chemical information and modeling
|June 26, 2024
概括
药物流是一个新的AI平台,简化了科学家的药物发现. 它集成了多个人工智能工具,用于高效的早期药物设计,从击中识别到领先优化.
科学领域:
- 计算化学是一种计算化学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 人工智能 (AI) 加快了现代药物发现.
- 复杂的人工智能工具和不太熟悉计算机的科学家之间存在差距.
- 需要用户友好的界面来民主化药物设计中的AI.
研究的目的:
- 介绍DrugFlow,一个人工智能驱动的平台,用于早期药物发现.
- 为复杂的AI算法提供简化,基于云的界面.
- 支持科学家进行打击识别和领先优化.
主要方法:
- 集成的AI算法用于分子对接.
- 定量结构-活动关系 (QSAR) 建模.
- 分子生成,ADMET预测和虚拟查.
主要成果:
- 药物流提供了一个统一的平台,用于各种AI驱动的药物设计任务.
- 该平台简化了早期药物发现工作流程.
- 为关键阶段提供AI解决方案,如击中识别和优化.
结论:
- 药物流弥合了人工智能和药物发现科学家之间的差距.
- 该平台旨在为现实世界药物设计提供有价值的指导.
- 通过基于云的接口,可以访问DrugFlow.
相关概念视频
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Drug Administration and Therapy Phases: Overview
446
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
446


